Progenics elects Crowley to serve as chairman (AP)
Biopharmaceutical company Progenics Pharmaceuticals Inc. said Thursday board member Peter J. Crowley was elected chairman at the company's annual meeting.

PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, (EDGAR Online)

Peter Crowley Elected Progenics Chairman of the Board (Business Wire)
TARRYTOWN, N.Y.----Progenics Pharmaceuticals, Inc. today announced the election of board member Peter J. Crowley as Chairman of the Board at the Company?s annual meeting. Mr. Crowley replaces Kurt Briner, who is stepping down as Chairman at the end of his term while remaining a director.

PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)

Progenics Phase 1 PSMA ADC Study Presented in New "Trials in Progress" Poster Session at ASCO Annual Meeting (Business Wire)
TARRYTOWN, N.Y. & CHICAGO----Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology .